BioSpace News Archive

BioCapital

Senseonics Announces Presentation of PROMISE Data at the American Diabetes Association 81st Scientific Sessions

Senseonics Holdings, Inc. today announced further presentation of PROMISE Study data evaluating the next generation Eversense CGM System at the American Diabetes Association Virtual 81st Annual Scientific Sessions.

June 28, 2021
·
3 min read
Business

Resolution Bioscience (a part of Agilent) Investigated Acquired Resistance to KRAS G12C Inhibition

Agilent Technologies Inc. (NYSE: A) today announced the publication of a study carried out in partnership with Resolution Bioscience (a part of Agilent) and Dana-Farber Cancer Institute .

June 28, 2021
·
3 min read
Biotech Bay

180 Life Sciences Joins Russell Microcap® Index

180 Life Sciences Corp. announced today that it has joined the Russell Microcap® Index, effective after the U.S. market opens today, June 28.

June 28, 2021
·
4 min read
Dyadic’s C1 Production Platform Utilized in ZAPI Study Published in “VACCINES” a Leading Peer-Reviewed Scientific Journal

Dyadic announced today findings from the Zoonotic Anticipation and Preparedness Initiative (ZAPI) project which has been published in VACCINES, a leading peer-reviewed scientific journal.

June 28, 2021
·
5 min read
Drug Development

Veru Announces the Presentation of a Phase 1b/2 Clinical Study Update for Sabizabulin (VERU-111) in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 European Association of Urology Annual Congress

Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancers, today announced updated clinical results from the ongoing Phase 1b/2 clinical study of sabizabulin (VERU-111)

June 28, 2021
·
9 min read
Biotech Beach

Cardiff Oncology Added to the Russell 2000® and other FTSE Russell Indexes

Cardiff Oncology, Inc. today announced that it has been added as a member of the small-cap Russell 2000® Index, the all-cap Russell 3000® Index, and the Russell Microcap® Index, effective upon the U.S. market open today, June 28, 2021, as part of the 2021 Russell indexes reconstitution.

June 28, 2021
·
4 min read
Biotech Bay

BioMarin Resubmits Marketing Authorization Application (MAA) to European Medicines Agency for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A

BioMarin Pharmaceutical Inc. announced today that the company resubmitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for its investigational gene therapy, valoctocogene roxaparvovec.

June 28, 2021
·
8 min read
Genetown

Myomo, Inc. Stock Added to Russell Microcap® Index

Myomo, Inc. Stock Added to Russell Microcap ® Index

June 28, 2021
·
2 min read
Biotech Bay

Sense Relief Receives Grant From UCSF-Stanford Pediatric Device Consortium for Further Development and Study of the Treatment for Pregnancy Related Nausea and Vomiting

Sense Relief, Inc. received an innovation grant from the UCSF-Stanford Pediatric Device Consortium for the continued technical development and further clinical study of Sense Relief, an antiemetic digital therapeutic

June 28, 2021
·
2 min read
Drug Development

Kite Announces Yescarta® CAR T-cell Therapy Improved Event-Free Survival by 60% Over Chemotherapy Plus Stem Cell Transplant in Second-Line Relapsed or Refractory Large B-cell Lymphoma

Kite Announces Yescarta ® CAR T-cell Therapy Improved Event-Free Survival by 60% Over Chemotherapy Plus Stem Cell Transplant in Second-Line Relapsed or Refractory Large B-cell Lymphoma

June 28, 2021
·
17 min read